Evidence map›Paper›PMID 32161321›Full record

ArticleBone marrow transplantation2020

Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.

Junya Kanda, Katsutsugu Umeda, Koji Kato, Makoto Murata, Junichi Sugita, Souichi Adachi, Katsuyoshi Koh, Maiko Noguchi, Hiroaki Goto, Nao Yoshida and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 1 country.

Junya KandaDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. jkanda16@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-6704-3633
Katsutsugu UmedaDepartment of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koji KatoDepartment of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Makoto MurataDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Junichi SugitaDepartment of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Souichi AdachiDepartment of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Katsuyoshi KohDepartment of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Maiko NoguchiDepartment of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Hiroaki GotoDivision of Hemato-Oncology/Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
Nao YoshidaDepartment of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.ORCID http://orcid.org/0000-0002-3783-2121
Maho SatoDepartment of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Yuhki KogaDepartment of Pediatrics, Kyushu University Hospital, Fukuoka, Japan.
Tsukasa HoriDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
Yuko ChoDepartment of Pediatrics, Hokkaido University Hospital, Sapporo, Japan.
Atsushi OgawaDepartment of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
Masami InoueDepartment of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Yoshiko HashiiDepartment of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Takanori TeshimaDepartment of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.ORCID http://orcid.org/0000-0002-0941-271X
JSHCT GVHD Working Group
Hokkaido University · JPKyoto University · JPNational Hospital Organization Kyushu Cancer Center · JPNiigata Cancer Center Hospital · JPOsaka International Cancer Institute · JPSapporo Medical University · JPKanagawa Children's Medical Center · JPKyushu University Hospital · JPNagoya University · JPThe Japanese Data Center for Hematopoietic Cell Transplantation · JP

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 18K08325
6 · The paper itself

Abstract

The effect of GVHD on transplant outcomes after unrelated cord blood transplantation (UCBT) is not yet fully understood. Pediatric patients aged 0-15 years with acute leukemia or myelodysplastic syndrome who underwent their first UCBT (n = 740) were selected from the Japanese registry. Fifty percent of the patients received a UCB unit containing more than 5.0 × 10

Indexed as

Cord Blood Stem Cell TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteMyelodysplastic SyndromesChildHumansTransplantation Conditioning

Identifiers

PMID32161321
OpenAlexW3012529056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.